The DOI matches its Crossref record; 35 of the 36 references it cites were found in a registry or an index.
Inflammatory Cytokine Concentrations Are Acutely Increased by Hyperglycemia in Humans: Role of Oxidative Stress
Abstract
Background— Circulating levels of interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) are elevated in diabetic patients. We assessed the role of glucose in the regulation of circulating levels of IL-6, TNF-α, and interleukin-18 (IL-18) in subjects with normal or impaired glucose tolerance (IGT), as well as the effect of the antioxidant glutathione. Methods and Results— Plasma glucose levels were acutely raised in 20 control and 15 IGT subjects and maintained at 15 mmol/L for 5 hours while endogenous insulin secretion was blocked with octreotide. In control subjects, plasma IL-6, TNF-α, and IL-18 levels rose ( P <0.01) within 2 hours of the clamp and returned to basal values at 3 hours. In another study, the same subjects received 3 consecutive pulses of intravenous glucose (0.33 g/kg) separated by a 2-hour interval. Plasma cytokine levels obtained at 3, 4, and 5 hours were higher ( P <0.05) than the corresponding values obtained during the clamp. The IGT subjects had fasting plasma IL-6 and TNF-α levels higher ( P <0.05) than those of control subjects. The increase in plasma cytokine levels during the clamping lasted longer (4 hours versus 2 hours, P <0.01) in the IGT subjects than in the control subjects, and the cytokine peaks of IGT subjects after the first glucose pulse were higher ( P <0.05) than those of control subjects. On another occasion, 10 control and 8 IGT subjects received the same glucose pulses as above during an infusion of glutathione; plasma cytokine levels did not show any significant change from baseline after the 3 glucose pulses. Conclusions— Hyperglycemia acutely increases circulating cytokine concentrations by an oxidative mechanism, and this effect is more pronounced in subjects with IGT. This suggests a causal role for hyperglycemia in the immune activation of diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similarly, a negative influence of postprandial hypertriglyceridemia on endothelial function has been reported in both normal and diabetic subjects.”
In the citing paper
“Other studies have demonstrated that fluctuations in blood glucose levels may contribute more to outcomes than constant high blood glucose concentrations.31–35”
From Increased Time in Range and Fewer Missed Bolus Injections After Introduction of a Smart Connected Insulin Pen (2020) · cites this paper as [32]
Citations
Cites
C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
Pradhan, A. D. (2001) · JAMA · doi:10.1001/jama.286.3.327 · Cited by 4,433
Ridker, P. M., Rifai, N., Stampfer, M. J., & Hennekens, C. H. (2000) · Circulation · doi:10.1161/01.cir.101.15.1767 · Cited by 2,429
Capes, S. E., Hunt, D., Malmberg, K., & Gerstein, H. C. (2000) · The Lancet · doi:10.1016/s0140-6736(99)08415-9 · Cited by 2,187
Subcutaneous Adipose Tissue Releases Interleukin-6, But Not Tumor Necrosis Factor-α,in Vivo1
Mohamed‐Ali, V., Goodrick, S., Rawesh, A., Katz, D. R., Miles, J. M., Yudkin, J. S., Klein, S., & Coppack, S. W. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.12.4450 · Cited by 2,032
Oxidative Stress and Diabetic Vascular Complications
Giugliano, D., Ceriello, A., & Paolisso, G. (1996) · Diabetes Care · doi:10.2337/diacare.19.3.257 · Cited by 1,921
Self-citationYuan, M., Konstantopoulos, N., Lee, J., Hansen, L., Li, Z.-W., Karin, M., & Shoelson, S. E. (2001) · Science · doi:10.1126/science.1061620 · Cited by 1,884
Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly
Harris, T. B., Ferrucci, L., Tracy, R. P., Corti, M. C., Wacholder, S., Ettinger, W. H., Heimovitz, H., Cohen, H. J., & Wallace, R. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00066-2 · Cited by 1,488
Pickup, J. C., Mattock, M. B., Chusney, G. D., & Burt, D. J. (1997) · Diabetologia · doi:10.1007/s001250050822 · Cited by 1,246
Ridker, P. M., Rifai, N., Pfeffer, M., Sacks, F., Lepage, S., & Braunwald, E. (2000) · Circulation · doi:10.1161/01.cir.101.18.2149 · Cited by 934
Activation of Receptor for Advanced Glycation End Products
Schmidt, A. M., Yan, S. D., Wautier, J., & Stern, D. M. (1999) · Circulation Research · doi:10.1161/01.res.84.5.489 · Cited by 799
Cited by
Sorted by citations
Items 201–300 of 1,003
Liu, C., Wong, P.-L., Lii, C., Hse, H., & Sheen, L. (2006) · Food and Chemical Toxicology · doi:10.1016/j.fct.2005.07.013 · Cited by 118
“An elevation of the inflammatory cytokines interleukin 6 and tumor necrosis factor a in plasma was shown in persons with uncontrolled diabetes, in healthy volunteers who underwent a hyperglycemic clamp procedure (Pickup et al., 2000; Esposito et al., 2002), and in isolated human monocytes challenged with a high concen…”
BackgroundElevated White Blood Cell Count in Subjects With Impaired Glucose Tolerance
Ohshita, K., Yamane, K., Hanafusa, M., Mori, H., Mito, K., Okubo, M., Hara, H., & Kohno, N. (2004) · Diabetes Care · doi:10.2337/diacare.27.2.491 · Cited by 117
“Hyperglycemic spikes have more influence on plasma tumor necrosis factor- , IL-6, and IL-18 concentrations than continuous hyperglycemia (24).”
BackgroundPrattichizzo, F., Nigris, V. D., Micheloni, S., Sala, L. L., & Ceriello, A. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13488 · Cited by 118
“It is noteworthy that postprandial, glycaemia-induced inflammation is a tangible phenomenon, even in humans, and that empagliflozin increases postprandial glucose excretion in T2DM patients.(66,68) Compared with other glucoselowering agents, the peculiar mechanism of action of SGLT2 inhibitors could rationally support…”
BackgroundSelf-citationStegenga, M. E., van der Crabben, S. N., Dessing, M. C., Pater, J. M., van den Pangaart, P. S., de Vos, A. F., Tanck, M. W. T., Roos, D., Sauerwein, H. P., & van der Poll, T. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02348.x · Cited by 117
Wong, C. K., Ho, A. M. ‐., Tong, P. C. Y., Yeung, C. Y., Kong, A. P. S., Lun, S. W., Chan, J. C. N., & Lam, C. W. K. (2007) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2007.03389.x · Cited by 115
Aso, Y., Okumura, K.-I., Takebayashi, K., Wakabayashi, S., & Inukai, T. (2003) · Diabetes Care · doi:10.2337/diacare.26.9.2622 · Cited by 114
“A hyperglycemic glucose clamp study has shown that plasma IL-18 increases within 2 h of clamping in both control subjects and subjects with impaired glucose tolerance (21).”
BackgroundInterleukin-18, the Metabolic Syndrome, and Subclinical Atherosclerosis
Zirlik, A., Abdullah, S. M., Gerdes, N., MacFarlane, L. A., Schönbeck, U., Khera, A., McGuire, D. K., Vega, G. L., Grundy, S. M., Libby, P., et al. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.149484 · Cited by 113
Caballero, A. E. (2004) · Current Diabetes Reports · doi:10.1007/s11892-004-0074-9 · Cited by 114
“Esposito et al. [ 51 ] recently reported elevated levels of”
BackgroundGiraldez, R. R., Clare, R. M., Lopes, R. D., Dalby, A. J., Prabhakaran, D., Brogan, G. X., Giugliano, R. P., James, S. K., Tanguay, J.-F., Pollack, C. V., et al. (2013) · American Heart Journal · doi:10.1016/j.ahj.2013.01.005 · Cited by 111
Atkin, M., Laight, D. W., & Cummings, M. H. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.01.003 · Cited by 115
Pinto, M. D. S., de Carvalho, J. E., Lajolo, F. M., Genovese, M. I., & Shetty, K. (2010) · Journal of Medicinal Food · doi:10.1089/jmf.2009.0257 · Cited by 113
Shim, W. S., Kim, H. J., Kang, E. S., Ahn, C. W., Lim, S. K., Lee, H. C., & Soo, B. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.02.001 · Cited by 112
Role of oxidative stress in diabetic nephropathy
Vasavada, N., & Agarwal, R. (2005) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2005.01.001 · Cited by 113
Glycemic Variability: Both Sides of the Story
Ceriello, A., & Kilpatrick, E. S. (2013) · Diabetes Care · doi:10.2337/dcs13-2030 · Cited by 111
“The role of oxidative stress also seems to be a key causative mechanism, since the use of an antioxidant reduced the phenomenon (14).”
BackgroundSelf-citationVergès, B. L. (2020) · Diabetes & Metabolism · doi:10.1016/j.diabet.2020.09.001 · Cited by 116
Wu, C., Wu, C., Huang, H., Jao, Y., & Yen, G. (2009) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200800495 · Cited by 111
Cardiovascular protection by SGLT2 inhibitors – Do anti-inflammatory mechanisms play a role?
Elrakaybi, A., Laubner, K., Zhou, Q., Hug, M. J., & Seufert, J. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101549 · Cited by 118
“The resulting hyperglycaemia plays a major role in inflammation and diabetic vascular complications which were shown to be also mediated by oxidative stress [46,47].”
BackgroundIncreased CD40 ligand and platelet–monocyte aggregates in patients with type 1 diabetes mellitus
Harding, S. A., Sommerfield, A., Sarma, J., Twomey, P. J., Newby, D. E., Frier, B. M., & Fox, K. A. A. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.05.008 · Cited by 110
“This concept is supported by recent studies demonstrating that acute in vivo hyperglycaemia leads to increases in plasma cytokine concentrations and platelet activation [24,25].”
ResultGreen, C., Pedersen, M., Pedersen, B. K., & Schéele, C. (2011) · Diabetes · doi:10.2337/db11-0263 · Cited by 110
“In support of this, it has been shown that in healthy individuals, clamping glucose at hyperglycemic levels (20 mmol/L) leads to a significant increase in plasma TNF-a, IL-18, and IL-6 within 2 h (23).”
BackgroundInflammation in Metabolic Cardiomyopathy
Wenzl, F. A., Ambrosini, S., Mohammed, S. A., Kraler, S. C., Lüscher, T. F., Costantino, S., & Paneni, F. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.742178 · Cited by 115
Cressman, A. M., Petrović, V., & Piquette‐Miller, M. (2011) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.11.66 · Cited by 112
Ohara, M., Fukui, T., Ouchi, M., Watanabe, K., Suzuki, T., Yamamoto, S., Yamamoto, T., Hayashi, T., Oba, K., & Hirano, T. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.09.025 · Cited by 105
Gupta, S. K., Dongare, S., Mathur, R., Mohanty, I. R., Srivastava, S., Mathur, S. R., & Nag, T. C. (2015) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-015-2483-2 · Cited by 107
“level activates NF-jB and induces the RAGE gene resulting in left ventricular (LV) dysfunction and cardiomyopathy [11–14].”
BackgroundPreshaw, P. M., Foster, N. M., & Taylor, J. J. (2007) · Periodontology 2000 · doi:10.1111/j.1600-0757.2007.00221.x · Cited by 111
Kallio, P., Kolehmainen, M., Laaksonen, D. E., Pulkkinen, L., Atalay, M., Mykkänen, H. M., Uusitupa, M. I. J., Poutanen, K. S., & NISKANEN, L. K. (2008) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.5.1497 · Cited by 108
“combined with hyperinsulinemia may increase circulating concentrations of radical oxygen species and proinflammatory cytokines (22, 23 ).”
Background[Inflammatory biomarkers: the link between obesity and associated pathologies].
Zulet, M. Á., Puchau, B., Navarro, C., Martí, A., & Martínez, J. A. (2007) · PubMed · Cited by 106
The Role of TLR2 and 4-Mediated Inflammatory Pathways in Endothelial Cells Exposed to High Glucose
Mudaliar, H., Pollock, C. A., Ma, J., Wu, H., Chadban, S. J., & Panchapakesan, U. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108844 · Cited by 106
“studies and clinical data support the deleterious effect of oscillating hyperglycemia on endothelial dysfunction compared to chronic sustained hyperglycemia [13–15], the impact of variability on the”
Diabetes-induced male infertility: potential mechanisms and treatment options
Huang, R., Chen, J., Guo, B., Jiang, C., & Sun, W. (2024) · Molecular Medicine · doi:10.1186/s10020-023-00771-x · Cited by 130
“…cells increases, resulting in excessive production of ROS in mitochondria, which causes oxidative damage and activates the inflammatory signaling cascade in endothelial cells, releasing a large number of inflammatory cytokines into the blood (Esposito et al. 2002; Don-ath and Shoelson 2011).”
BackgroundBastos, A. D. S., Graves, D. T., Loureiro, A. P. D. M., Rossa, C., Abdalla, D. S. P., Faulin, T. D. E. S., Câmara, N. O. S., Andriankaja, O. M., & Orrico, S. R. P. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3397 · Cited by 105
“Previous studies reported that oxidative stress induced by diabetic status triggers the release of cytokines and enhances their activation (39) and that diabetics, especially those with poor metabolic control, have increased levels of inflammatory cytokines in plasma and in GCF (40).”
BackgroundPostprandial dysmetabolism and cardiovascular disease in type 2 diabetes
Tushuizen, M. E., Diamant, M., & Heine, R. J. (2005) · Postgraduate Medical Journal · doi:10.1136/pgmj.2004.020511 · Cited by 104
Belalcazar, L. M., Reboussin, D. M., Haffner, S. M., Hoogeveen, R. C., Kriska, A. M., Schwenke, D. C., Tracy, R. P., Pi-Sunyer, X., & Ballantyne, C. M. (2010) · Diabetes Care · doi:10.2337/dc10-0728 · Cited by 104
“The mechanisms that would explain this finding are difficult to determine, given that the effects were reported to be independent of weight gain and because it has been previously shown that hyperglycemia stimulates inflammatory cytokine production (24).”
BackgroundBiobaku, F., Ghanim, H., Batra, M., & Dandona, P. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01833 · Cited by 104
Zhang, C., Lu, X., Tan, Y., Li, B., Miao, X., Jin, L., Shi, X., Zhang, X., Miao, L., Li, X., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049257 · Cited by 104
“Other primary antibodies, including tumor necrosis factor-a (TNF-a, 1:500), total- and phospho-Akt (Ser473, 1:500), total and phosphor-GSK-3b (1:500), total- and phosphor-tensin homolog (PTEN, 1: 500), cleaved caspase-12 (1:1000), Fyn (1:1000), Bax and Bcl-2 (1: 1000) were purchased from Cell Signaling Technology (Dan…”
BackgroundWang, C., Yen, H., Lu, W., Ho, H.-H., Lin, W., Kuo, Y., Huang, Y.-Y., Tsai, S., & Lin, H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.754401 · Cited by 115
“Previous studies discovered that elevation in the concentrations of inflammatory cytokines such as TNF-a associated with glycemic control and cardiovascular risk factors among patients with T1DM (53).”
BackgroundCytokine Milieu Tends Toward Inflammation in Type 2 Diabetes
Esposito, K., Nappo, F., Giugliano, F., Palo, C. D., Ciotola, M., Barbieri, M., Paolisso, G., & Giugliano, D. (2003) · Diabetes Care · doi:10.2337/diacare.26.5.1647 · Cited by 103
Self-citationCieślak, M., Wojtczak, A., & Cieślak, M. (2015) · Acta Biochimica Polonica · doi:10.18388/abp.2014_853 · Cited by 102
Ishihara, M., Inoue, I., Kawagoe, T., SHIMATANI, Y., Kurisu, S., Hata, T., Nakama, Y., Kijima, Y., & Kagawa, E. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl271 · Cited by 102
“Age (years) 62.2+ 12.5 62.7+ 11.6 64.9+ 12.6 0.31 Men, n(%) 72 (89) 69 (86) 28 (78) 0.11 Hypertension, n(%) 27 (33) 36 (43) 17 (47) 0.11 Current smoking, n(%) 45 (56) 44 (53) 19 (53) 0.74 Prior myocardial infarction, n(%) 14 (17) 9 (11) 1 (3) 0.03 Killip class � 2, n(%) 2 (2) 16 (19) 4 ( 11 ) 0.03 Anterior location, n…”
InfluentialThe potential effects of anti-diabetic medications on myocardial ischemia–reperfusion injury
Ye, Y., Perez-Polo, J. R., Aguilar, D. A., & Birnbaum, Y. (2011) · Basic Research in Cardiology · doi:10.1007/s00395-011-0216-6 · Cited by 101
“The effects of DM and hyperglycemia are wide ranging and include systemic inflammation [41, 114, 136, 193], endothelial dysfunction [75, 136, 152, 193], hypercoagulability with impaired fibrinolysis [133, 134] and increased platelet degranulation [44, 175], reduced coronary collateral blood flow [87], and interference…”
González‐Clemente, J. M., Mauricio, D., Richart, C., Broch, M., Caixàs, A., Megía, A., Giménez‐Palop, O., Simón, I., Martínez-Riquelme, A., Giménez‐Pérez, G., et al. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02376.x · Cited by 101
Hyperglycemia as a risk factor for surgical site infections in patients undergoing mastectomy
Vilar‐Compte, D., de Iturbe, I. Á., Martin‐Onraët, A., Pérez-Amador, M., Sánchez-Hernández, C., & Volkow, P. (2008) · American Journal of Infection Control · doi:10.1016/j.ajic.2007.06.003 · Cited by 101
Björck, I., Östman, E. M., Kristensen, M., Anson, N. M., Price, R. K., Haenen, G. R. M. M., Havenaar, R., Knudsen, K. E. B., Frid, A. H., Mykkänen, H. M., et al. (2011) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2011.11.005 · Cited by 101
The roles of insulin and hyperglycemia in sepsis pathogenesis
Andersen, S. K., Gjedsted, J., Christiansen, C. F., & Tønnesen, E. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0503195 · Cited by 102
“Hyperglycemia has been found to influence the production of proinflammatory cytokines acutely and chronically [110].”
BackgroundPramlintide and the treatment of diabetes: a review of the data since its introduction
Younk, L. M., Mikeladze, M., & Davis, S. N. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.581663 · Cited by 102
“Under acute hyperglycemic challenges, several studies have shown increases in markers of endothelial dysfunction, atherothrombosis, inflammation and oxidative stress [4-8].”
BackgroundInteractions between adipose tissue and the immune system in health and malnutrition
Wensveen, F. M., Marinović, S., Šestan, M., Wensveen, T. T., & Polić, B. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2015.10.006 · Cited by 103
Chatzigeorgiou, A., Harokopos, V., Mylona-Karagianni, C., Tsouvalas, E., Aidinis, V., & Kamper, E. F. (2010) · Annals of Medicine · doi:10.3109/07853890.2010.495951 · Cited by 98
Lieshout, R. J. V., & Voruganti, L. P. (2008) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0837 · Cited by 100
Oxidative Stress in Diabetes Mellitus
Chikezie, P. C., Ojiako, O. A., & Ogbuji, A. C. (2015) · International Journal of Biological Chemistry · doi:10.3923/ijbc.2015.92.109 · Cited by 100
“The activation of NFκB promotes increase in expression of a variety of cytokines such as tumor necrosis factors (TNF-α and TNF-β), interleukins (IL) 1, 6, 8 and 18 and interferon-γ, even in the presence of intact antioxidant mechanisms, which may engender overt diabetic nephropathy with associated glomerulosclerosis […”
Colom, C., Rull, A., Sánchez‐Quesada, J. L., & Pérez, A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10081798 · Cited by 109
Qi, L., & Hu, F. B. (2007) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328011c6e0 · Cited by 99
Insulin: An endogenous cardioprotector
Das, U. N. (2003) · Current Opinion in Critical Care · doi:10.1097/00075198-200310000-00007 · Cited by 97
Thromboxane-Dependent CD40 Ligand Release in Type 2 Diabetes Mellitus
Santilli, F., Davı̀, G., Consoli, A., Cipollone, F., Mezzetti, A., Falco, A., Taraborelli, T., Devangelio, E., Ciabattoni, G., Basili, S., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.03.079 · Cited by 97
“Inflammatory ytokines, adhesion molecules, and chemokines, although nvolved in mediating all phases of atherothrombotic disases (5), have also been implicated in the development of iabetes and its complications (6,7).”
BackgroundEitel, I., Hintze, S., de Waha, S., Fuernau, G. F., Lurz, P. C., Desch, S., Schuler, G. C., & Thiele, H. (2012) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.112.974998 · Cited by 97
“Hyperglycemia also influences coagulation, as it is associated with increased platelet aggregation as well as circulating clotting factors and is associated with increased markers of vascular inflammation.(35,36) Finally, consistent with our findings microvascular dysfunction and the no-reflow phenomenon were demonstr…”
Jonasson, L., Guldbrand, H., Lundberg, A. K., & Nyström, F. H. (2014) · Annals of Medicine · doi:10.3109/07853890.2014.894286 · Cited by 97
“This effect is also more pronounced in subjects with obesity or impaired glucose tolerance (32,33).”
BackgroundLiu, J., Liu, Y., Chen, C., Chang, W., & Chen, C. O. (2012) · European Journal of Nutrition · doi:10.1007/s00394-012-0400-y · Cited by 97
“Although mechanism(s) regulating inflammation in T2DM patients has not yet been clearly established, oxidative stress induced by hyperglycemia might partially play an underlying factor via NFjB pathway [45].”
BackgroundShort-term Hyperglycemia in Surgical Patients and a Study of Related Cellular Mechanisms
Turina, M., Miller, F. N., Tucker, C., & Polk, H. C. (2006) · Annals of Surgery · doi:10.1097/01.sla.0000220041.68156.67 · Cited by 97
“Among these are a disturbance in the inflammatory cytokine cascade with increasing levels of early proinflammatory cytokines such as IL-6 or TNF- in response to hyperglycemia.(14,15) High glucose levels are also known to impair the microvasculature’s ability to relax in the presence of vasodilating stimuli such as nit…”
BackgroundOxidative stress and antioxidant status in patients with late-onset gestational diabetes mellitus
López‐Tinoco, C., Roca, M., García-Valero, A., Murri, M., Tinahones, F. J., Segundo, C., Bartha, J. L., & Aguilar‐Diosdado, M. (2011) · Acta Diabetologica · doi:10.1007/s00592-011-0264-2 · Cited by 98
“The injurious effects of oxidative stress in the cardiovascular system are numerous and varied but can be summarised as the reduction in the availability of nitric oxide [18, 19], increase in the inflammatory markers implicated in accelerated atherosclerosis [20–23] and modifications of lipids and lipoproteins [24, 25…”
BackgroundLane, J. T. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00247.2003 · Cited by 97
“Acute hyperglycemia has been shown to increase IL-6, TNF- , and IL-18 (27).”
BackgroundValue of Self-Monitoring Blood Glucose Pattern Analysis in Improving Diabetes Outcomes
Parkin, C. G., & Davidson, J. A. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300314 · Cited by 96
Does garlic have a role as an antidiabetic agent?
Liu, C., Sheen, L., & Lii, C. (2007) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200700082 · Cited by 96
Yu, W. (2003) · World Journal of Gastroenterology · doi:10.3748/wjg.v9.i8.1824 · Cited by 96
Cruz, M., Maldonado‐Bernal, C., Mondragón-González, R., Sánchez-Barrera, R. G., Wacher, N. H., Carvajal‐Sandoval, G., & Kumate, J. (2008) · Journal of Endocrinological Investigation · doi:10.1007/bf03346417 · Cited by 96
Nettleton, J. A., Harnack, L., Scrafford, C., Mink, P. J., Barraj, L. M., & Jacobs, D. R. (2006) · Journal of Nutrition · doi:10.1093/jn/136.12.3039 · Cited by 99
“Type 2 diabetes may be caused by chronic inflammation leading to impaired b-cell function (1–4) and insulin resistance (5,6).”
BackgroundPerioperative management of hyperglycemia and diabetes in cardiac surgery patients
Galindo, R. J., Fayfman, M., & Umpierrez, G. E. (2018) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2017.10.005 · Cited by 95
“Increasing evidence indicates that development of hyperglycemia leads to the generation of reactive oxygen species (ROS), which affect different biological signaling pathways.(47) ROS are formed from the reduction of molecular oxygen or by oxidation of water to yield products, such as superoxide anion, hydrogen peroxi…”
BackgroundTang, X., Li, S., Wang, Y., Wang, M., Yin, Q., Mu, P., Lin, S., Qian, X., Ye, X., & Chen, Y. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.08.004 · Cited by 97
Moazen, S., Amani, R., Rad, A. H., Shahbazian, H. B., Angali, K. A., & Jalali, M. T. (2013) · Annals of Nutrition and Metabolism · doi:10.1159/000356053 · Cited by 95
Cavalot, F. L. (2013) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12140 · Cited by 97
“Data in humans show that repeated glycaemic oscillations increase the levels of proinflammatory cytokines in normal subjects and induce endothelial dysfunction both in normal subjects and in subjects with T2DM [40].”
BackgroundDiabetes, oxidative stress, molecular mechanism, and cardiovascular disease – an overview
Selvaraju, V., Joshi, M., Suresh, S. C., Sánchez, J. A., Maulik, N., & Maulik, G. (2012) · Toxicology Mechanisms and Methods · doi:10.3109/15376516.2012.666648 · Cited by 94
“Recent in vivo studies support the hypothesis that free fatty acid and glucose triggers inflammation via oxidative stress, individually and in combination and that antioxidants reverse the phenomenon (Esposito et al. 2002; Roebuck 1999; Tripathy et al. 2003).”
BackgroundConte, L., & Toraldo, D. M. (2020) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753466620937170 · Cited by 96
Molecular Basis of Health and Disease
Das, U. N. (2011) · Springer eBooks · doi:10.1007/978-94-007-0495-4 · Cited by 95
Protein and energy provision in critical illness
Hoffer, L. J. (2003) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/78.5.906 · Cited by 93
“The harmful effects of high-energy TPN are attributed to hyperglycemia, which induces immediate adverse metabolic responses (16, 17) and is associated with a greater infection risk and larger ischemic infarctions than is euglycemia (18– 21).”
BackgroundMarfella, R., Di Filippo, C., Esposito, K., Nappo, F., Piegari, E., Cuzzocrea, S., Berrino, L., Rossi, F., Giugliano, D., & D’Amico, M. (2004) · Diabetes · doi:10.2337/diabetes.53.2.454 · Cited by 92
“Interesting enough, acute hyperglycemia in healthy subjects and in patients with impaired glucose tolerance increases the circulating levels of these cytokines (25), which are also able to stimulate the production of iNOS by mononuclear and mesenchymal cells (26).”
BackgroundSelf-citationDiabetes-induced osteoarthritis: from a new paradigm to a new phenotype
Berenbaum, F. (2012) · Postgraduate Medical Journal · doi:10.1136/pgmj.2010.146399rep · Cited by 92
Soft drink intake and the risk of metabolic syndrome: A systematic review and meta-analysis
Narain, A., Kwok, C. S., & Mamas, M. A. (2017) · International Journal of Clinical Practice · doi:10.1111/ijcp.12927 · Cited by 95
Takotsubo Syndrome in Patients with COVID-19: a Systematic Review of Published Cases
Singh, S., Desai, R., Gandhi, Z., Fong, H. K., Doreswamy, S., Desai, V., Chockalingam, A., Mehta, P. K., Sachdeva, R., & Kumar, G. (2020) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-020-00557-w · Cited by 93
Campbell, M. D., Walker, M., Trenell, M. I., Luzio, S. D., Dunseath, G. J., Tuner, D., Bracken, R. M., Bain, S. C., Russell, M. A., Stevenson, E., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097143 · Cited by 92
“Patients with type 1 diabetes exhibit chronically elevated levels of inflammatory markers at baseline [7–10,35].”
Hyperglycaemia and pulmonary infection
Baker, E. H., Wood, D. M., Brennan, A. L., Clark, N., Baines, D. L., & Philips, B. J. (2006) · Proceedings of The Nutrition Society · doi:10.1079/pns2006499 · Cited by 92
“The stimulatory effect of glucose on IL-6 and TNF-a production is ameliorated by glutathione infusion, implying that an oxidative mechanism is involved (Esposito et al. 2002).”
BackgroundInfluentialRoad Maps to Achieve Glycemic Control in Type 2 Diabetes Mellitus
Jellinger, P. S., Davidson, J. A., Blonde, L., EINHORN, D. F., Grunberger, G., Handelsman, Y., Hellman, R., Lebovitz, H. E., Levy, P., & Roberts, V. L. (2007) · Endocrine Practice · doi:10.4158/ep.13.3.260 · Cited by 92
Visser, L., Zuurbier, C. J., Hoek, F. J., Opmeer, B. C., de Jonge, E., de Mol, B. A. J. M., & van Wezel, H. B. (2005) · British Journal of Anaesthesia · doi:10.1093/bja/aei220 · Cited by 92
“Total pump time (min) 90 (26) 86 (43) Total cross-clamp time (min) 57 ( 17 ) 57 (34) Number of grafts 4 (1) 4 (1) Temperature during aortic cross-clamping (� C) 32.9 (1.1) 33.4 (2.2) Time on ventilator support in ICU (h) 17 (5) 18 (3) Inotropic score* <1 <1 Duration of ICU stay (h) 26 (8) 26 (5) Total hospital stay (d…”
BackgroundInfluentialPriebe, M. G., Wang, H., Weening, D., Schepers, M., Preston, T., & Vonk, R. J. (2009) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.28521 · Cited by 91
El‐Ashmawy, H. M., Selim, F. O., Hosny, T., & Almassry, H. N. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.02.026 · Cited by 93
Kumar, P., Natarajan, K., & Shanmugam, N. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.11.031 · Cited by 92
Parenteral iron therapy exacerbates experimental sepsis Rapid Communication
Zager, R. A., Johnson, A. C. M., & Hanson, S. Y. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00742.x · Cited by 91
“That antioxidants can attenuate NF-κB and AP-1 expression, and thus, suppress inflammation, supports this pathophysiologic lin”
BackgroundZhu, Y., Olsen, S. F., Mendola, P., Yeung, E. H., Vaag, A. A., Bowers, K. A., Liu, A., Bao, W., Li, S., Madsen, C., et al. (2016) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.115.121780 · Cited by 89
“Consistently, epidemiologic data corroborate that offspring of diabetic women are predisposed to fetal programming or metabolic imprinting via hyperinsulinemia (36), glucose intolerance (37), augmented inflammation response (38), or perturbations in epigenetic modifications (39), which in turn are positively related t…”
BackgroundFatima, M. T., Bhat, A. A., Nisar, S., Fakhro, K. A., & Akil, A. A. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e12698 · Cited by 112
“Dietary intake of flavonoids is associated with biomarkers of insulin resistance and systemic inflammation, such as fasting insulin levels, C-reactive protein, and interleukin (IL)-6 [180].”
BackgroundComing full circle in diabetes mellitus: from complications to initiation
Harcourt, B. E., Penfold, S. A., & Forbes, J. M. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.236 · Cited by 91
Diabetes mellitus in patients with chronic obstructive pulmonary disease-The impact on mortality
Ho, T., Huang, C., Ruan, S., Tsai, Y., Lai, F., & Yu, C. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175794 · Cited by 90
Functional foods and nutraceuticals as therapeutic tools for the treatment of diet-related diseases
Magrone, T., de Heredia, F. P., Jirillo, E., Morabito, G., Marcos, A., & Serafini, M. (2013) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2012-0307 · Cited by 91
“2006), IL-6 (Esposito et al. 2002; Nappo et al. 2002; Manning et al. 2008; Gregersen et al. 2012), IL-17 (Peluso et al.”
BackgroundInfluentialTrøseid, M., Seljeflot, I., Hjerkinn, E. M., & Arnesen, H. (2008) · Diabetes Care · doi:10.2337/dc08-1710 · Cited by 89
“On the other hand, experimental hyperglycemia has been shown to increase concentrations of IL18 (17).”
BackgroundMetabolic syndrome X: An inflammatory condition?
Das, U. N. (2004) · Current Hypertension Reports · doi:10.1007/s11906-004-0014-8 · Cited by 88
Sugar‐Sweetened Beverage Intake and Cardiovascular Disease Risk in the California Teachers Study
Pacheco, L. S., Lacey, J. V., Martı́nez, M. E., Lemus, H., Araneta, M. R. G., Sears, D. D., Talavera, G. A., & Anderson, C. A. M. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.014883 · Cited by 96
Tanha, K., Mottaghi, A., Nojomi, M., Moradi, M., Rajabzadeh, R., Lotfi, S., & Janani, L. (2021) · Journal of Ovarian Research · doi:10.1186/s13048-021-00911-z · Cited by 88
“Based on numerous animal and clinical studies, hyperglycemia is related to oxidative stress [20].”
BackgroundAronson, D., & Edelman, E. R. (2010) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-010-9135-3 · Cited by 90
“Hyperglycemia promotes inflammation [35,36], induces the production of growth factors that promote restenosis [27] and increases matrix gene transcriptions [37].”
Fuji, S., Kim, S.-W., Mori, S., Fukuda, T., Kamiya, S., Yamasaki, S., Morita‐Hoshi, Y., Ohara-Waki, F., Honda, O., Kuwahara, S., et al. (2007) · Transplantation · doi:10.1097/01.tp.0000296482.50994.1c · Cited by 88
Miyauchi, K., Takiyama, Y., Honjo, J., Tateno, M., & Haneda, M. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.11.018 · Cited by 88
Reductive stress after exercise: The issue of redox individuality
Margaritelis, N. V., Kyparos, A., Paschalis, V., Theodorou, A. A., Panayiotou, G., Zafeiridis, A., Δίπλα, Κ., Nikolaidis, M. G., & Vrabas, I. S. (2014) · Redox Biology · doi:10.1016/j.redox.2014.02.003 · Cited by 92
Okopień, B., Krysiak, R. G., & Herman, Z. S. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1615 · Cited by 88
Albacker, T. B., Carvalho, G., Schricker, T., & Lachapelle, K. J. (2008) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2008.03.046 · Cited by 89
“Thereore, to focus all of one’s attention on Yin and ignore ang, or vice versa, may well turn out not to be the best pproach to take [3].”
BackgroundGao, C., Guo, J., Gong, T.-T., Lv, J.-L., Li, X.-Y., Liu, F.-H., Zhang, M., Shan, Y.-T., Zhao, Y.-H., & Wu, Q.-J. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2021.813943 · Cited by 88
Chew, B. P., Mathison, B. D., Kimble, L. L., McKay, D. L., Kaspar, K. L., Khoo, C., Chen, C. O., & Blumberg, J. B. (2018) · European Journal of Nutrition · doi:10.1007/s00394-018-1643-z · Cited by 99
“Further, impaired glucose tolerance and hyperglycemia have been shown to acutely increase inflammatory cytokine concentrations [25].”
BackgroundResponses of inflammatory markers to a low-fat, high-carbohydrate diet: effects of energy intake
Kasim-Karakas, S. E., Tsodikov, A., Singh, U. S., & Jialal, I. (2006) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.4.774 · Cited by 87
“In further support, Esposito et al (36) showed that intravenous glucose administration increased concentrations of the inflammatory markers IL-6, IL-18, and tumor necrosis factor ; this could be prevented by simultaneous infusion of the antioxidant glutathione.”
Background
Metadata
- Authors
- Esposito, K., Nappo, F., Marfella, R., Giugliano, G., Giugliano, F., Ciotola, M., Quagliaro, L., Ceriello, A., & Giugliano, D.
- Affiliations
- University of Udine (IT)
- Venue
- Circulation
- Published
- 2002-10-15
- Volume
- 106
- Issue
- 16
- Pages
- 2067-2072
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2123560318
- Cited by
- 1,961
- References
- 36
- Citations by year
- 2026: 57 · 2025: 69 · 2024: 88 · 2023: 95 · 2022: 106 · 2021: 91 · 2020: 102 · 2019: 83 · 2018: 86 · 2017: 70 · 2016: 87 · 2015: 112 · 2014: 99 · 2013: 102 · 2012: 101
- FWCI
- 38.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System (University of Udine) (submittedVersion)
- Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- hyperglycemia, inflammatory cytokines, interleukin-6, TNF-α, IL-18, impaired glucose tolerance, glutathione, oxidative stress, glucose clamp
- MeSH terms
- Adult, Antioxidants, Blood Glucose, Diabetes Mellitus, Type 2, Female, Glucose Tolerance Test, Glutathione, Humans, Inflammation, Kinetics, Male, Tumor Necrosis Factor-alpha, Interleukin-6, Cytokines, Glucose Intolerance, Oxidative Stress, Interleukin-18
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review